» Articles » PMID: 29940308

Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis

Overview
Date 2018 Jun 26
PMID 29940308
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Eosinophilic gastrointestinal diseases (EGIDs) are a rare group of disorders that can have varied clinical presentations dependent on the involved segment within the gastrointestinal tract. Eosinophilic gastritis presents with abdominal pain or vomiting, eosinophilic gastroenteritis presents with diarrhea and anemia or hypoalbuminemia, and eosinophilic colitis can present with diarrhea or bloody stools. These nonspecific symptoms remain poorly understood in their relation to the underlying pathogenesis, but a significant percentage of patients have atopy. In this review, we discuss the current literature on EGIDs to promote a practical approach to diagnosis and care.

Data Sources: Review of published literature.

Study Selections: Clinically relevant literature from 1900 through 2018 was obtained from a PubMed search. Those that addressed prevalence, diagnosis, clinical manifestations, natural history, and treatment of EGIDs were reviewed and are summarized in this article.

Results: Of the 485 articles found in the search, most of which were case reports, 71 were selected for review. The natural history of EGIDs is based primarily on case series and small numbers of patients, making therapeutic decisions difficult. Treatment remains limited to dietary restriction that is not effective in many patients and topical or systemic corticosteroids whose long-term use is to be avoided if possible.

Conclusion: With the seeming increase in all types of EGIDs, phenotypic descriptions are emerging that will likely promote better understanding of the pathogenesis and identification of novel therapeutic targets.

Citing Articles

Advances in Biologic Therapies for Allergic Diseases: Current Trends, Emerging Agents, and Future Perspectives.

Alska E, Laszczych D, Napiorkowska-Baran K, Szymczak B, Rajewska A, Rubisz A J Clin Med. 2025; 14(4).

PMID: 40004611 PMC: 11856668. DOI: 10.3390/jcm14041079.


Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis.

Zeng B, Jia D, Li S, Liu X, Zhu B, Zhang Y Ann Med. 2024; 57(1):2445192.

PMID: 39707826 PMC: 11703371. DOI: 10.1080/07853890.2024.2445192.


Eosinophilic gastrointestinal disorders: a narrative review on clinical perspectives and research gaps in the Asian context.

Chiou F, Ng L, Loh W Transl Gastroenterol Hepatol. 2024; 9:69.

PMID: 39503038 PMC: 11535809. DOI: 10.21037/tgh-24-34.


Systemic Mastocytosis Imitating Eosinophilic Enterocolitis.

Muller T, Van Der Merwe K, Steele C, Papanikolaou M, ODowd G, Parihar V Gastro Hep Adv. 2024; 1(3):417-419.

PMID: 39131682 PMC: 11307762. DOI: 10.1016/j.gastha.2022.02.001.


Spatial adaptation of eosinophils and their emerging roles in homeostasis, infection and disease.

Arnold I, Munitz A Nat Rev Immunol. 2024; 24(12):858-877.

PMID: 38982311 DOI: 10.1038/s41577-024-01048-y.